138 related articles for article (PubMed ID: 2803327)
1. Activation of the complement system in systemic sclerosis. Relationship to clinical severity.
Senaldi G; Lupoli S; Vergani D; Black CM
Arthritis Rheum; 1989 Oct; 32(10):1262-7. PubMed ID: 2803327
[TBL] [Abstract][Full Text] [Related]
2. Complement activation products in idiopathic pulmonary fibrosis: relevance of fragment Ba to disease severity.
Meliconi R; Senaldi G; Sturani C; Galavotti V; Facchini A; Gasbarrini G; Vergani D
Clin Immunol Immunopathol; 1990 Oct; 57(1):64-73. PubMed ID: 2394036
[TBL] [Abstract][Full Text] [Related]
3. Complement activation before, during and after cardiopulmonary bypass.
Bonser RS; Dave JR; John L; Gademsetty MK; Carter PG; Davies E; Taylor P; Gaya H; Lennox SC; Vergani D
Eur J Cardiothorac Surg; 1990; 4(6):291-6. PubMed ID: 2361017
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
Senaldi G; Makinde VA; Vergani D; Isenberg DA
Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
[TBL] [Abstract][Full Text] [Related]
5. Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
Senaldi G; Peakman M; McManus T; Davies ET; Tee DE; Vergani D
J Infect Dis; 1990 Dec; 162(6):1227-32. PubMed ID: 1977807
[TBL] [Abstract][Full Text] [Related]
6. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
[TBL] [Abstract][Full Text] [Related]
8. Complement activation in neonatal infection.
Peakman M; Senaldi G; Liossis G; Gamsu HR; Vergani D
Arch Dis Child; 1992 Jul; 67(7 Spec No):802-7. PubMed ID: 1519979
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.
Kao AH; Navratil JS; Ruffing MJ; Liu CC; Hawkins D; McKinnon KM; Danchenko N; Ahearn JM; Manzi S
Arthritis Rheum; 2010 Mar; 62(3):837-44. PubMed ID: 20187154
[TBL] [Abstract][Full Text] [Related]
10. A flow cytometric assay for measuring complement receptor 1 (CR1) and the complement fragments C3d and C4d on erythrocytes.
Freysdottir J; Sigfusson A
J Immunol Methods; 1991 Aug; 142(1):45-52. PubMed ID: 1833467
[TBL] [Abstract][Full Text] [Related]
11. Different patterns of C3 and C4 activation in the varied types of juvenile arthritis.
Miller JJ; Olds LC; Silverman ED; Milgrom H; Curd JG
Pediatr Res; 1986 Dec; 20(12):1332-7. PubMed ID: 3099253
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of complement activation products in Chinese patients with systemic lupus erythematosus.
Li J; An L; Zhang Z
Clin Exp Rheumatol; 2014; 32(1):48-53. PubMed ID: 23981509
[TBL] [Abstract][Full Text] [Related]
13. Alterations in C3, C4, factor B, and related metabolites in septic shock.
Lin RY; Astiz ME; Saxon JC; Saha DC; Rackow EC
Clin Immunol Immunopathol; 1993 Nov; 69(2):136-42. PubMed ID: 8403550
[TBL] [Abstract][Full Text] [Related]
14. Pattern of C3, iC3b, and C3d in patients hospitalized for acute asthma.
Lin RY; Caveliere LF; Lorenzana FG; Go EF; Altman KA
Ann Allergy; 1992 Apr; 68(4):324-30. PubMed ID: 1558328
[TBL] [Abstract][Full Text] [Related]
15. Complement activation by cellulosic dialysis membranes.
Innes A; Farrell AM; Burden RP; Morgan AG; Powell RJ
J Clin Pathol; 1994 Feb; 47(2):155-8. PubMed ID: 8132830
[TBL] [Abstract][Full Text] [Related]
16. Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis.
Okrój M; Johansson M; Saxne T; Blom AM; Hesselstrand R
Arthritis Res Ther; 2016 Nov; 18(1):267. PubMed ID: 27863511
[TBL] [Abstract][Full Text] [Related]
17. C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome.
Kuypers DR; Lerut E; Evenepoel P; Maes B; Vanrenterghem Y; Van Damme B
Transplantation; 2003 Jul; 76(1):102-8. PubMed ID: 12865794
[TBL] [Abstract][Full Text] [Related]
18. The absence of factor B activation products in scleroderma.
Valeriano-Marcet J; Kerr LD; Spiera H
J Rheumatol; 1992 May; 19(5):729-31. PubMed ID: 1613702
[TBL] [Abstract][Full Text] [Related]
19. Complement activation in severe Plasmodium falciparum malaria.
Wenisch C; Spitzauer S; Florris-Linau K; Rumpold H; Vannaphan S; Parschalk B; Graninger W; Looareesuwan S
Clin Immunol Immunopathol; 1997 Nov; 85(2):166-71. PubMed ID: 9344699
[TBL] [Abstract][Full Text] [Related]
20. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
Lood C; Eriksson S; Gullstrand B; Jönsen A; Sturfelt G; Truedsson L; Bengtsson AA
Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
